NDLI: Fluoroquinolone antibiotics and type 2 diabetes mellitus.

Content Provider	World Health Organization (WHO)-Global Index Medicus
Author	Telfer, Stephen J.
Spatial Coverage	United States
Description	Author Affiliation: Telfer SJ ( E Ink Corporation, 1000 Technology Park Drive, Billerica, MA 01821, USA. Electronic address: sjtelfer@gmail.com.)
Abstract	Exposure to fluoroquinolone antibiotics is postulated as a risk factor for subsequent development of type 2 diabetes. It is hypothesized that fluoroquinolones induce an intracellular magnesium deficit that can lead to insulin resistance. A temporal correlation is reported between the rate of outpatient prescription of quinolones and the incidence of diabetes during the period 1980-2011 with a lag of approximately two years (R(2)=0.86, P<10(-9)). The increase in incidence of diabetes after 1990 and the recent decrease in the number of new cases are both reflected in the fluoroquinolone prescription rates. A geographical correlation is reported (adj. R(2)=0.7, P<0.0001) between rates of increase in prevalence of diabetes in each U.S. state and a model using only local rates of outpatient fluoroquinolone prescription, local rates of increase in the prevalence of obesity, and local rates of population growth as predictor variables. Prescription rates of non-quinolone antibiotics correlated less well with the local rates of increase in prevalence of diabetes. The data are consistent with fluoroquinolone exposure predisposing an individual to develop diabetes with a probability that strongly depends upon factors that also lead to an increase in obesity. According to the hypothesis, much of the increase in the incidence of type 2 diabetes in the U.S. from 1990 to the present can be attributed to fluoroquinolone exposure.
File Format	HTM / HTML
ISSN	03069877
Issue Number	3
Volume Number	83
e-ISSN	15322777
Journal	Medical Hypotheses
Language	English
Publisher	Elsevier
Publisher Date	2014-09-01
Publisher Place	United States
Access Restriction	One Nation One Subscription (ONOS)
Subject Keyword	Discipline Medical theory Anti-bacterial Agents Adverse Effects Diabetes Mellitus, Type 2 Epidemiology Fluoroquinolones Adolescent Adult Aged Humans Incidence Linear Models Middle Aged Prevalence Risk Factors Time Factors United States Young Adult Journal Article
Content Type	Text
Resource Type	Article
Subject	Medicine

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Disease burden of urinary tract infections among type 2 diabetes mellitus patients in the U.S.

Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus.

Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.

Prevalence and risk factors for albuminuria among type 2 diabetes mellitus patients: a Middle-East perspective.

Diabetes in the Africa Region: an update.

A mathematical model for determining age-specific diabetes incidence and prevalence using body mass index

Cardiovascular disease among women with and without diabetes mellitus and bilateral oophorectomy.

FDA adds 'black box' warning label to fluoroquinolone antibiotics.

The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.

Fluoroquinolone antibiotics and type 2 diabetes mellitus.

Similar Documents

Disease burden of urinary tract infections among type 2 diabetes mellitus patients in the U.S.

Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus.

Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.

Prevalence and risk factors for albuminuria among type 2 diabetes mellitus patients: a Middle-East perspective.

Diabetes in the Africa Region: an update.

A mathematical model for determining age-specific diabetes incidence and prevalence using body mass index

Cardiovascular disease among women with and without diabetes mellitus and bilateral oophorectomy.

FDA adds 'black box' warning label to fluoroquinolone antibiotics.

The relationship between inpatient fluoroquinolone use and Clostridium difficile-associated diarrhea.

Fluoroquinolone antibiotics and type 2 diabetes mellitus.